• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

二碘水杨酸酯和氟灭酸与血浆抗激活剂的结合:化学纤维蛋白溶解分析

The binding of diiodosalicylate and flufenamate to the plasma antiactivator: analysis of chemical fibrinolysis.

作者信息

Nanninga L B

出版信息

Thromb Haemost. 1979 Apr 23;41(2):357-64.

PMID:572998
Abstract

The fibrinolytic effect of diiodosalicylate was expressed as apparent units urokinase. The dissociation constant of the urokinase-inhibitor complex is increased 19 times in the presence of 10(-2) M diiodosalicylate. The binding of diiodosalicylate to the antiactivator was estimated and the increase in free urokinase in the presence of diiodosalicylate was calculated. With 10(-2) M diiodosalicylate present only 4% of the inhibitor remains free to bind urokinase. Therefore, the fibrinolytic action of diiodosalicylate can be explained on the basis of its binding to the inhibitor and the release of free urokinase.

摘要

二碘水杨酸的纤溶作用以表观尿激酶单位表示。在存在10⁻² M二碘水杨酸的情况下,尿激酶 - 抑制剂复合物的解离常数增加了19倍。估算了二碘水杨酸与抗激活剂的结合,并计算了在二碘水杨酸存在下游离尿激酶的增加量。当存在10⁻² M二碘水杨酸时,只有4%的抑制剂仍可自由结合尿激酶。因此,二碘水杨酸的纤溶作用可以基于其与抑制剂的结合以及游离尿激酶的释放来解释。

相似文献

1
The binding of diiodosalicylate and flufenamate to the plasma antiactivator: analysis of chemical fibrinolysis.二碘水杨酸酯和氟灭酸与血浆抗激活剂的结合:化学纤维蛋白溶解分析
Thromb Haemost. 1979 Apr 23;41(2):357-64.
2
Purification and properties of an antiactivator fraction from bovine serum.牛血清中一种抗激活剂组分的纯化及性质
Thromb Haemost. 1979 Oct 31;42(3):855-63.
3
Molar concentrations of fibrinolytic components, especially free fibrinolysin, in vivo.体内纤溶成分的摩尔浓度,尤其是游离纤溶酶。
Thromb Diath Haemorrh. 1975 Apr 30;33(2):244-55.
4
Comparison of the relative fibrinogenolytic, fibrinolytic and thrombolytic properties of tissue plasminogen activator and urokinase in vitro.组织型纤溶酶原激活剂与尿激酶在体外的相对纤维蛋白溶解、纤溶及溶栓特性比较
Thromb Haemost. 1981 Jun 30;45(3):225-9.
5
Blood fibrinolytic system in rana tigrina.虎纹蛙的血液纤溶系统。
Thromb Haemost. 1981 Jun 30;45(3):252-4.
6
Inhibition of Borrelia burgdorferi-bound fibrinolytic enzymes by alpha2-antiplasmin, PAI-1 and PAI-2.α2-抗纤溶酶、纤溶酶原激活物抑制剂-1(PAI-1)和纤溶酶原激活物抑制剂-2(PAI-2)对伯氏疏螺旋体结合的纤溶酶的抑制作用。
Biochem Biophys Res Commun. 1996 Feb 27;219(3):690-5. doi: 10.1006/bbrc.1996.0296.
7
Kinetics of the reaction between urokinase and an inhibitor of fibrinolysis from placental tissue.尿激酶与胎盘组织纤溶抑制物之间反应的动力学
Thromb Haemost. 1982 Aug 24;48(1):24-6.
8
[Serial changes in hemostatic and fibrinolytic states induced by coronary thrombolytic therapy].[冠状动脉溶栓治疗引起的止血和纤溶状态的系列变化]
J Cardiol. 1993;23(4):335-41.
9
Substrate composition and the effect of epsilon-aminocaproic acid on tissue plasminogen activator and urokinase-induced fibrinolysis.底物组成及ε-氨基己酸对组织型纤溶酶原激活物和尿激酶诱导的纤维蛋白溶解的影响。
Thromb Diath Haemorrh. 1974 Dec 31;32(2-3):306-24.
10
Interaction between plasminogen activator inhibitor type 1 (PAI-1) bound to fibrin and either tissue-type plasminogen activator (t-PA) or urokinase-type plasminogen activator (u-PA). Binding of t-PA/PAI-1 complexes to fibrin mediated by both the finger and the kringle-2 domain of t-PA.与纤维蛋白结合的1型纤溶酶原激活物抑制剂(PAI-1)与组织型纤溶酶原激活物(t-PA)或尿激酶型纤溶酶原激活物(u-PA)之间的相互作用。t-PA的指状结构域和kringle-2结构域介导t-PA/PAI-1复合物与纤维蛋白的结合。
J Clin Invest. 1989 Aug;84(2):647-55. doi: 10.1172/JCI114211.